| ²é¿´: 566 | »Ø¸´: 0 | |||
gy_xmc2015ͳæ (СÓÐÃûÆø)
|
[½»Á÷]
ÎÄÕÂÍÆ¼ö£üAntonios G. Mikos×ÛÊö£ºËûÍ¡ÀàÒ©ÎïÔÚ¹Ç÷ÀÔÙÉúÁìÓòµÄÐÂÓ¦ÓÃ
|
|
http://nsr.oxfordjournals.org/content/2/1/85.full ABSTRACT The use of statins for bone regeneration is a promising and growing area of research. Statins, originally developed to treat high cholesterol, are inhibitors of the enzyme 3-hydroxy-3-methylglutaryl, the rate-limiting enzyme of the mevalonate pathway. Because the mevalonate pathway is responsible for the synthesis of a wide variety of important biochemical molecules, including cholesterol and other isoprenoids, the effects of statins are pleiotropic. In particular, statins can greatly affect the process of bone turnover and regeneration via effects on important cell types, including mesenchymal stem cells, osteoblasts, endothelial cells, and osteoclasts. Statins have also been shown to have anti-inflammatory and antimicrobial properties that may be useful since infection can derail normal bone healing. This review will explore the pleiotropic effects of statins, discuss the current use of statins for bone regeneration, particularly with regard to biomaterials-based controlled delivery, and offer perspectives on the challenges and future directions of this emerging area of bone tissue engineering. Keywords: tissue engineering, osteogenesis, statin, HMG-CoA reductase, local delivery |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : Natl_Sci_Rev-2015-Shah-85-99.pdf
2016-05-25 09:53:08, 755.69 K
» ²ÂÄãϲ»¶
Ïôó309·ÖÉúÎïÓëÒ½Ò©µ÷¼Á
ÒѾÓÐ0È˻ظ´
334ÉúÎïÇóµ÷¼Á
ÒѾÓÐ0È˻ظ´
ÉúÎïÁ¦Ñ§Óë×éÖ¯¹¤³ÌѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ300È˻ظ´
Ò»Ö¾Ô¸ÖÐɽ´óѧÉúÎïѧ£¬295·Ö£¬ÇóAÇøµ÷¼Á
ÒѾÓÐ2È˻ظ´
ÇóÖú»¯ºÏÎïCDÊý¾ÝµÄ´¦Àí
ÒѾÓÐ0È˻ظ´
¹ãÖÝÒ½¿Æ´óѧÉúÎïҽѧ¹¤³ÌѧԺ ÉúÎïҽѧ¹¤³Ì¹¤Ñ§-083100 ÕÐÉú
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ºþÄÏ´óѧ ÉúÎïѧ332·Ö Óйú½±+Ê¡¼¶
ÒѾÓÐ1È˻ظ´
ÃÀ¹úÄϼӴó(USC)ҩѧԺProf. Yong (Tiger) Zhang¿ÎÌâ×é³ÏƸ²©Ê¿ºó
ÒѾÓÐ0È˻ظ´
ºþ±±¹¤Òµ´óѧʳƷ¿ÆÑ§Ó빤³Ìϵ¿ÎÌâ×éÕÐÊÕ2026¼¶Ê³Æ·/ÉúÎïҽҩ˶ʿÉú£¨º¬µ÷¼Á£©
ÒѾÓÐ0È˻ظ´
2026Ä격ʿÉú×ÔÎÒÍÆ¼ö
ÒѾÓÐ0È˻ظ´













»Ø¸´´ËÂ¥